Search Our Blog

 Subscribe to Our Blog!

Innovative Ideas for Global Patient Recruitment

Current Articles | RSS Feed RSS Feed

Adaptive Patient Recruitment: A New Specialty in Clinical Trial Marketing


Last month, at the DIA's Annual Meeting in San Diego, we launched Adaptive Patient Recruitment, a new specialty in clinical trial marketing that helps solve today's unique challenges around global enrollment. Through a custom and balanced mix of cutting-edge technology, data-driven consultation, and strategic branding and advertising, our Adaptive Patient Recruitment discipline allows today's global study community to work more collaboratively, respond rapidly to often unforeseen enrollment challenges, and make more informed decisions at critical study milestones.

Stuart Scott Bravely Shares Clinical Trial Experience at ESPYS

dm 140716 Stuart Scott Accepts Jimmy V Award default resized 600

There wasn't a dry eye in the audience last night when the acclaimed ESPN veteran Stuart Scott accepted his Jimmy V Perseverance Award at the 2014 ESPYS last night. The longtime SportsCenter personality opened up about his seven-year battle with appendiceal cancer – in which he has endured fifty-eight chemotherapy infusions, three abdomen surgeries and countless treatments as he continues to fight the disease.

Three Challenges to Implementing Social Media Into Your Patient Recruitment Campaign

FG online Main 1 large resized 600

Considering a social media campaign for your clinical trial? While there are proven advantages to using social media as a patient recruitment tactic, additional considerations must be explored when deciding if social media fits your campaign’s needs. First, scope out your audience by evaluating the opportunity with a social media listening program. For example, how active and engaged is this study community on social media? Or, how many Facebook groups, outlets, etc. are out there for these patients to find each other? Next, evaluate the outlet – What are all my options when building a social media page? Or, what outlets can I use if I just want to advertise?

FDA Proposes Social Media Guidelines. Sort of.

!Q6UJ9A01D69AICT Summer 2012 p24  (4) rev resized 600

A few weeks ago, and nearly five years after its open hearing on the topic, the Food and Drug Administration (FDA) finally released its proposed guidelines for how drug and device makers should navigate social media. Much has been written on the new guidelines including a few informative posts by Ed Silverman at the Wall Street Journal. As Silverman notes, among the 50 largest drug makers, half are still not using social media to engage consumers or patients, according to a survey by the IMS Institute for Health Informatics. He also suggests that the FDA will likely use the guidances as trial-and-error blueprints themselves as they run across questions that were not answered or situations that may not have been anticipated.

Meaningful Data Analysis and Adaptive Patient Recruitment Tactical Efficacy

describe the image

This is the second part of a two-part series by Joan F. Bachenheimer, founding principal, and Matt Kibby, principal, technology and innovation, BBK Worldwide.

Even if you were able to correlate advertising referrals to consented patients with a high degree of accuracy (and then to screen-fail and randomization) the fact of the matter is, "So what?"

Four scenarios spring to mind with regard to the quest for this correlation:

Japan's CROèe Inc. To Establish US-Based Clinical Trial Recruitment Company With BBK Worldwide


DIA 2014 50th Annual Meeting, SAN DIEGO, Calif. and BOSTON, Mass., June 17, 2014 --BBK Worldwide, a leading clinical trial marketing firm, and CROèe, the first consulting Japanese CRO specializing in patient recruitment, today announced the creation of a jointly-owned US-based company, BBK + CROèe. Collaborators since 2010, the new partners formed the entity to provide the cultural and marketing expertise necessary to engage the Japanese pharmaceutical industry and, in turn, to support global pharma in its quest for drug approvals in Japan, the second largest pharmaceutical marketplace in the world next to the US.

BBK Worldwide Makes Clinical Engagement Process Easier With Mobile Apps


Underscoring its Commitment to Patient Advocacy and Care, My Clinical Study BuddySM Mobile Apps to Help Boost Patient Engagement

Mobile Apps to Streamline Valuable Resource and Information Sharing, Better Connect Advocacy Groups, Pharmaceutical Sponsors and Patients

DIA 2014 50th Annual Meeting, SAN DIEGO, Calif. and BOSTON, Mass., June 16, 2014--BBK Worldwide, a leading clinical trial marketing firm, today unveiled two new mobile apps for patient and site engagement, My Clinical Study BuddySM and My Clinical Study BuddySM Protocol Pointers Edition. Available for Apple® and Android mobile phones and tablets, both apps are available today on iTunes® and the Google Play store and are being demoed at this week's DIA 2014 50th Annual Meeting at the San Diego Convention Center, San Diego, Calif., June 16-19 at BBK booth #2309.

BBK Worldwide Unveils "Adaptive Recruitment" Reshaping Patient Recruitment For Clinical Trials


New R&D Model Protects Performance in a Threatened Enrollment Landscape

DIA 2014 50th Annual Meeting, SAN DIEGO, Calif. and BOSTON, Mass., June 16, 2014--BBK Worldwide, the leader in patient recruitment, today unveiled a new specialty in clinical trial marketing: adaptive  recruitment. Designed specifically to protect global enrollment integrity, within a changing or threatened landscape, adaptive recruitment helps sites and sponsors maximize tight budgets and timeframes by offering the tools and best-practices needed to ensure more informed recruitment and enrollment decisions – and the ability to seamlessly employ real-time corrections as needed. BBK Principal Matthew Stumm will discuss this new model in detail during his DIA Annual Meeting presentation, "Adopting New Strategies for the New Face of Patient Recruitment," on Tuesday, June 17 at 2:45 p.m. PST.

50th Annual Meeting of the Drug Information Association: Celebrate the Past - Invent the Future

bbk adaptive recruitment car dia resized 600

It's that time again... The Annual Meeting of the Drug Information Association is here! This year is the DIA's 50th anniversary, and to mark the occasion, the event's theme is "Celebrate the Past - Invent the Future." We anticipate numerous presentations and discussions about where the industry has come and where it's headed. We are delighted to bring a patient recruitment perspective to the conversation.

Walk the DIA Exhibit Hall Floor With Patient Fellows

describe the image

The 50th Annual Meeting of the DIA is right around the corner! Today we're excited to kick off our promotion with a guest blog from our friend, Lani Hashimoto. Lani is an expert in global patient recruitment and retention with 19 years of clinical trial experience within global pharmaceuticals. In this post, Lani tells us about the Exhibit Hall Guide volunteer program she has coordinated at this year's Annual Meeting in an effort to facilitate networking opportunities between Patient Fellows and the pharmaceutical industry. So far, we've recruited two BBKers to volunteer and hope that you and your colleagues will participate, too!

All Posts